Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...

A pickleball tournament and silent auction will be held to support the Lindblad family and raise awareness for epithelioid ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

PHILADELPHIA, PA & CARLSBAD, CA — Fox Chase Cancer Center and Arima Genomics, Inc. have launched a first-of-its-kind ...

The family of 17-year-old, Ayomide Amdi, has appealed to the public for financial assistance to enable him access life-saving ...

According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...

YouTube gaming channel GrammaCrackers is making headlines as the internet praises its goal. Sue Jacquot, an 81-year-old from Phoenix, Arizona, started the channel GrammaCrackers in the summer of 2025.

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

In a retrospective analysis, moderately hypofractionated definitive radiotherapy (MHDRT) achieved 1-year local control rates of more than 90% for soft tissue sarcomas (STS) and 100% for chordomas in ...

It’s been just over a year since the FDA approved the first engineered cell therapy for the treatment of certain patients with advanced synovial sarcoma, a rare cancer that affects fewer than 1000 ...